Cargando…

Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors

BACKGROUND: Typical high throughput microarrays experiments compare gene expression across two specimen classes – an experimental class and baseline (or comparison) class. The choice of specimen classes is a major factor in the differential gene expression patterns revealed by these experiments. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandran, Uma R, Dhir, Rajiv, Ma, Changqing, Michalopoulos, George, Becich, Michael, Gilbertson, John
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1173092/
https://www.ncbi.nlm.nih.gov/pubmed/15892885
http://dx.doi.org/10.1186/1471-2407-5-45
_version_ 1782124454810222592
author Chandran, Uma R
Dhir, Rajiv
Ma, Changqing
Michalopoulos, George
Becich, Michael
Gilbertson, John
author_facet Chandran, Uma R
Dhir, Rajiv
Ma, Changqing
Michalopoulos, George
Becich, Michael
Gilbertson, John
author_sort Chandran, Uma R
collection PubMed
description BACKGROUND: Typical high throughput microarrays experiments compare gene expression across two specimen classes – an experimental class and baseline (or comparison) class. The choice of specimen classes is a major factor in the differential gene expression patterns revealed by these experiments. In most studies of prostate cancer, histologically malignant tissue is chosen as the experimental class while normal appearing prostate tissue adjacent to the tumor (adjacent normal) is chosen as the baseline against which comparison is made. However, normal appearing prostate tissue from tumor free organ donors represents an alterative source of baseline tissue for differential expression studies. METHODS: To examine the effect of using donor normal tissue as opposed to adjacent normal tissue as a baseline for prostate cancer expression studies, we compared, using oligonucleotide microarrays, the expression profiles of primary prostate cancer (tumor), adjacent normal tissue and normal tissue from tumor free donors. RESULTS: Statistical analysis using Significance Analysis of Microarrays (SAM) demonstrates the presence of unique gene expression profiles for each of these specimen classes. The tumor v donor expression profile was more extensive that the tumor v adjacent normal profile. The differentially expressed gene lists from tumor v donor, tumor v adjacent normal and adjacent normal v donor comparisons were examined to identify regulated genes. When donors were used as the baseline, similar genes are highly regulated in both tumor and adjacent normal tissue. Significantly, both tumor and adjacent normal tissue exhibit significant up regulation of proliferation related genes including transcription factors, signal transducers and growth regulators compared to donor tissue. These genes were not picked up in a direct comparison of tumor and adjacent normal tissues. CONCLUSIONS: The up-regulation of these gene types in both tissue types is an unexpected finding and suggests that normal appearing prostate tissue can undergo genetic changes in response to or in expectation of morphologic cancer. A possible field effect surrounding prostate cancers and the implications of these findings for characterizing gene expression changes in prostate tumors are discussed.
format Text
id pubmed-1173092
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11730922005-07-07 Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors Chandran, Uma R Dhir, Rajiv Ma, Changqing Michalopoulos, George Becich, Michael Gilbertson, John BMC Cancer Research Article BACKGROUND: Typical high throughput microarrays experiments compare gene expression across two specimen classes – an experimental class and baseline (or comparison) class. The choice of specimen classes is a major factor in the differential gene expression patterns revealed by these experiments. In most studies of prostate cancer, histologically malignant tissue is chosen as the experimental class while normal appearing prostate tissue adjacent to the tumor (adjacent normal) is chosen as the baseline against which comparison is made. However, normal appearing prostate tissue from tumor free organ donors represents an alterative source of baseline tissue for differential expression studies. METHODS: To examine the effect of using donor normal tissue as opposed to adjacent normal tissue as a baseline for prostate cancer expression studies, we compared, using oligonucleotide microarrays, the expression profiles of primary prostate cancer (tumor), adjacent normal tissue and normal tissue from tumor free donors. RESULTS: Statistical analysis using Significance Analysis of Microarrays (SAM) demonstrates the presence of unique gene expression profiles for each of these specimen classes. The tumor v donor expression profile was more extensive that the tumor v adjacent normal profile. The differentially expressed gene lists from tumor v donor, tumor v adjacent normal and adjacent normal v donor comparisons were examined to identify regulated genes. When donors were used as the baseline, similar genes are highly regulated in both tumor and adjacent normal tissue. Significantly, both tumor and adjacent normal tissue exhibit significant up regulation of proliferation related genes including transcription factors, signal transducers and growth regulators compared to donor tissue. These genes were not picked up in a direct comparison of tumor and adjacent normal tissues. CONCLUSIONS: The up-regulation of these gene types in both tissue types is an unexpected finding and suggests that normal appearing prostate tissue can undergo genetic changes in response to or in expectation of morphologic cancer. A possible field effect surrounding prostate cancers and the implications of these findings for characterizing gene expression changes in prostate tumors are discussed. BioMed Central 2005-05-13 /pmc/articles/PMC1173092/ /pubmed/15892885 http://dx.doi.org/10.1186/1471-2407-5-45 Text en Copyright © 2005 Chandran et al; licensee BioMed Central Ltd.
spellingShingle Research Article
Chandran, Uma R
Dhir, Rajiv
Ma, Changqing
Michalopoulos, George
Becich, Michael
Gilbertson, John
Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
title Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
title_full Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
title_fullStr Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
title_full_unstemmed Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
title_short Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
title_sort differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1173092/
https://www.ncbi.nlm.nih.gov/pubmed/15892885
http://dx.doi.org/10.1186/1471-2407-5-45
work_keys_str_mv AT chandranumar differencesingeneexpressioninprostatecancernormalappearingprostatetissueadjacenttocancerandprostatetissuefromcancerfreeorgandonors
AT dhirrajiv differencesingeneexpressioninprostatecancernormalappearingprostatetissueadjacenttocancerandprostatetissuefromcancerfreeorgandonors
AT machangqing differencesingeneexpressioninprostatecancernormalappearingprostatetissueadjacenttocancerandprostatetissuefromcancerfreeorgandonors
AT michalopoulosgeorge differencesingeneexpressioninprostatecancernormalappearingprostatetissueadjacenttocancerandprostatetissuefromcancerfreeorgandonors
AT becichmichael differencesingeneexpressioninprostatecancernormalappearingprostatetissueadjacenttocancerandprostatetissuefromcancerfreeorgandonors
AT gilbertsonjohn differencesingeneexpressioninprostatecancernormalappearingprostatetissueadjacenttocancerandprostatetissuefromcancerfreeorgandonors